Last reviewed · How we verify
NCT04613635
Stratafix vs. Vicryl OAGB / MGB Suture Study
NA trial testing Stratafix in Morbid Obesity in 100 participants. Completed in 30 April 2024.
27 October 2023
Quick facts
| Lead sponsor | St. Franziskus Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 6 November 2020 |
| Primary completion | 27 October 2023 |
| Estimated completion | 30 April 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Stratafix
- Vicryl — full drug profile →
Conditions studied
- Morbid Obesity — all drugs for Morbid Obesity →
- Anastomotic Leak — all drugs for Anastomotic Leak →
- Anastomotic Stenosis — all drugs for Anastomotic Stenosis →
- Hemorrhage Postoperative — all drugs for Hemorrhage Postoperative →
Sponsor
St. Franziskus Hospital
Who can join
18 and older, any sex, with Morbid Obesity or Anastomotic Leak. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare shorttime (6 months) results of two competitive suture materials with regard to time demanded to perform the concerned surgical step and secondary to study anastomotic site safety and complications like leakage and hemorrhage as well as development of anastomotic strictures. Evaluation of cost-effectiveness.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04613635
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stratafix
Trials testing the same drug.
- NCT04356976 — Ventralex Vs Stratafix for Primary Ventral Hernias · NA · completed
Other recruiting trials for Morbid Obesity
Currently open trials in the same condition.
- NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
- NCT06413264 — Ultrasonography Guided Pneumoperitoneum for Laparoscopic Surgery in Morbidly Obese Patients · NA · recruiting
- NCT07289555 — Tailored Stapled SADI-S: Initial Report and Preliminary Results · NA · recruiting
- NCT07263269 — Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in · NA · active not recruiting
- NCT06293703 — Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study) · NA · recruiting
Other St. Franziskus Hospital trials
Trials by the same sponsor.
- NCT07137676 — Monitoring and Cognitive Appraisal: The Etiology of Psychological Disorders and The Divergence Between Behavioural and S · NA · completed
- NCT03391401 — Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04613635 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Franziskus Hospital
- Last refreshed: 17 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04613635.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing